- Investing Ideas
- /
- Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
8
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
8 companies
Abbott India
Market Cap: ₹676.0b
Operates as a pharmaceutical company in India.
500488
₹31,813.05
7D
3.7%
1Y
14.1%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹575.3b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹3,396.15
7D
3.8%
1Y
30.5%
Sanofi India
Market Cap: ₹142.1b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹6,169.25
7D
0.5%
1Y
-37.6%
Procter & Gamble Health
Market Cap: ₹94.4b
Engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally.
500126
₹5,689.95
7D
-1.2%
1Y
13.1%
Jeena Sikho Lifecare
Market Cap: ₹56.0b
Trades in ayurvedic medicines in India.
JSLL
₹2,251.55
7D
8.6%
1Y
109.3%
RPG Life Sciences
Market Cap: ₹35.6b
An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.
RPGLIFE
₹2,154.80
7D
-0.8%
1Y
40.0%
Ind-Swift Laboratories
Market Cap: ₹5.6b
Develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally.
INDSWFTLAB
₹94.29
7D
14.8%
1Y
-17.8%
Genesis IBRC India
Market Cap: ₹262.7m
Does not have significant operations.
514336
₹20.21
7D
5.0%
1Y
n/a